| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Mepolizumab (Nucala) (TX.CC.PHAR.14) | |
| Ambetter Health Texas Superior Marketplace Clinical | Nadofaragene firadenovec-vncg (Adstiladrin) (TX.CC.PHAR.31) | |
| Ambetter Health Texas Superior Marketplace Clinical | Nusinersen (Spinraza) (TX.CC.PHAR.01) | |
| Ambetter Health Texas Superior Marketplace Clinical | Obecabtagene autoleucel (Aucatzyl®) (TX.CC.PHAR.50) | |
| Ambetter Health Texas Superior Marketplace Clinical | Omalizumab (Xolair) (TX.CC.PHAR.15) | |
| Ambetter Health Texas Superior Marketplace Clinical | Onasemnogene Abeparvovec-xioi (Zolgensma) (TX.CC.PHAR.08) | |
| Ambetter Health Texas Superior Marketplace Clinical | Remestemcel-L-rknd (Ryoncil) TX.CC.PHAR.54) | |
| Ambetter Health Texas Superior Marketplace Clinical | Reslizumab (Cinqair) (TX.CC.PHAR.16) | |
| Ambetter Health Texas Superior Marketplace Clinical | Revakinagene taroretcel-lwey (Encelto) (TX.CC.PHAR.53) | |
| Ambetter Health Texas Superior Marketplace Clinical | Teplizumab-mzwv (Tzield) (TX.CC.PHAR.23) | |